LifeStrands Genomics Australia was established with a focus on precision oncology
We offer advanced genetic tests for a variety of tumour types
We truly strive to be at the cutting edge of genomic testing

CREATING A BENCHMARK IN MOLECULAR ONCOLOGY BIOMARKER TESTING

A dedicated team of medical professionals work together in our NATA and CAP accredited laboratory to deliver high quality and reliable solutions for clinicians and their patients.

Our team of scientists and cutting-edge equipment enable us to deliver a spectrum of translational genomic, clinical, and research services; leveraging the latest advancements in next generation sequencing and other genomic platforms.

Connect with us to find out more.

Quality

We aim to provide the highest quality in genetic testing

discover more >

Turnaround Times

We guarantee fast turnaround times with results available via our secure web portal

discover more >

Cost

Making affordable genetic testing accessible for everyone

discover more >

Consistency

Our laboratory maintains ongoing Quality Assurance Programs to ensure tests and equipment are always up to standard

discover more >

Quality

We aim to provide the highest quality in genetic testing

discover more >

Turnaround Times

LifeStrands understands the importance of fast turnaround times for reports

discover more >

Cost

Making affordable genetic testing accessible for everyone

discover more >

Consistency

Our laboratory maintains ongoing Quality Assurance Programs to ensure tests and equipment are always up to standard

discover more >

WE TRULY RECOGNISE THAT EVERY CANCER PATIENT
IS UNIQUE, AS ARE THEIR GENETIC VARIATIONS

OUR VISION

Making genomics accessible for a healthier world

OUR MISSION

Continuously innovate in the field of clinical genomics to advance precision medicine

OUR MISSION

Continuously innovate in the field of clinical genomics to advance precision medicine

OUR VALUES

Trust

Care

Innovation

The Pursuit of

With Integrity

For Others

That Impacts

Excellence

Trust

Care

With Integrity

For Others

Innovation

The Pursuit of

That Impacts

Excellence

ABOUT US

CLINICIANS

BLOG

CONTACT

Facebook Linkedin
Copyright © 2024 Lifestrands Genomics Australia

PAH2-1

Turnaround Times

We understand the importance of timely results which is crucial for cancer patient management.

Result turnaround times for our assays are class-leading, ranging from approximately 4 to 14 working days from specimen receipt in our laboratory.

Estimated turnaround times for some of our assays upon receiving the specimen in our laboratory –

  1. OncoStrands™ Essential Panel – within 5 working days
  2. OncoStrands™ DNA 68 Panel – within 10 working days
  3. OncoStrands™ Extended Panel – within 10 working days
  4. OncoStrands™ Comprehensive Fusion Panel – within 10 working days
  5. OncoStrands™ Comprehensive Panel – within 14 working days

Consistency

LifeStrands participates in a variety of national and international Quality Assurance Programs, not only to satisfy the conditions for fulfilling on-going accreditation and compliance requirements but also to maintain the highest standards and reliability of our test results.

We are currently enrolled in the following Quality Assurance Programs – 

  1. RCPA QAP
  2. CAP PT program, and
  3. EMQN 

Cost

We use currently available Medicare rebateable items for all types of solid tumour testing offered through our laboratory. Given below is the list of Medicare items and tests utilised against each item, for which there is no out of pocket cost for eligible patients –

  1. NSCLC – Medicare # 73437 (DNA variants : EGFR, BRAF, KRAS and MET; fusions: ALK, ROS1, RET, NTRK1/2/3), Essential Combined panel
  2. NSCLC – Medicare # 73438 (EGFR, BRAF, KRAS, MET), Essential DNA panel
  3. NSCLC – Medicare # 73351 (EGFR T790), Essential DNA panel
  4. NSCLC – Medicare # 73439 (ALK, ROS1, RET, NTRK1/2/3), Essential Fusion panel
  5. Colorectal cancer – Medicare # 73338 (KRAS, NRAS), Essential DNA panel
  6. Melanoma – Medicare # 73336 (BRAF), Essential DNA panel
  7. Glioma (Including Glioneuronal Tumour, Glioblastoma) – Medicare # 73429 (IDH1/2, 1p19q co-deletion, others), Neuro-oncology panel
  8. Glioblastoma – Medicare # 73373, MGMT methylation
  9. Secretory ca breast/salivary – Medicare # 73433 (NTRK 1/2/3 fusions), Essential RNA panel
  10. Tumour agnostic <18 yrs (Paediatric) – Medicare # 73433 (NTRK 1/2/3 fusions), Essential RNA panel
  11. Prostate – Medicare # 73303 (BRCA1/2), Extended panel
  12. Ovarian – Medicare # 73301 (BRCA1/2), Extended panel
  13. Ovarian – Medicare # 73307 (HRD, BRCA1/2), Comprehensive + HRD panel
  14. Sarcoma – Medicare # 73376, Comprehensive Fusion panel

Please contact LifeStrands Genomics Australia for tests that attract out-of-pocket fees.

Quality

Our laboratory is full accredited for compliance with NPAAC standards and ISO 15189.

We are the first Australian laboratory to receive full accreditation by the College of American Pathologists (CAP), and the first Australian laboratory to hold dual NATA and CAP accreditations.